Greco E M, Arlotti M, Lotto A
G Ital Cardiol. 1978;8 Suppl 1:217-22.
In 49 patients with sick sinus syndrome the following electrophysiological parameters were studied: sinus node recovery time and conduction time, atrial and AV nodal refractory periods, atrioventricular and intraventricular conduction. Moreover, pharmacological, vagal and sympathicomimetic stimulation were performed. These data were related to the clinical picture to establish any possible correlation leading to a more specific therapeutical choice. Patients were divided in two groups: group 1, with a prevalence of tachyarrhythmic symptoms and a lesser incidence of syncope, in which cases the sinus node function appeared to be only slightly affected. In group 2 small incidence of tachyarrhythmias and a clear prevalence of syncope with severe impairment of sinusal automaticity and/or sinoatrial conduction were present; AV and IV conduction disturbances were equally distributed in both groups. In more than 1/3 of the cases of the group I arrhythmias were succesfully treated with pharmacological therapy only, with Group 1 A antiarrhythmic agents in most cases. In the other cases of this Group and in all cases of Group II permanent electrical stimulation alone or together with drug therapy was necessary. Long term results with different therapeutical choices and, specifically, with the type of stimulation chosen in individual cases (sequential, rate-programmable ventricular, demand ventricular) are presented.
对49例病态窦房结综合征患者研究了以下电生理参数:窦房结恢复时间和传导时间、心房及房室结不应期、房室及室内传导。此外,还进行了药物、迷走神经及拟交感神经刺激。将这些数据与临床表现相关联,以确定是否存在任何可能的关联,从而做出更具针对性的治疗选择。患者被分为两组:第1组,快速性心律失常症状较多,晕厥发生率较低,在这些病例中,窦房结功能似乎仅受到轻微影响。第2组,快速性心律失常发生率较低,晕厥明显较多,伴有严重的窦房结自律性和/或窦房传导受损;房室和室内传导障碍在两组中分布相同。在第1组超过1/3的病例中,心律失常仅通过药物治疗成功治愈,大多数情况下使用ⅠA类抗心律失常药物。在该组的其他病例以及第2组的所有病例中,单独或联合药物治疗进行永久性电刺激是必要的。本文展示了不同治疗选择的长期结果,特别是个别病例中所选刺激类型(顺序性、频率程控心室、按需心室)的长期结果。